On July 2, UBTECH Robotics fell 5.64% in regular trading, trading at 96.6 HKD/share, with turnover of HKD 1.219 billion.

On the news front, UBTECH officially launched its full-size ultra-bionic humanoid robot U1 series on June 30, priced between RMB 119,800 and RMB 990,000, with total orders exceeding 13,000 units. The stock had surged over 15% on launch day, but a classic profit-taking pullback followed as the market reassessed the company's commercialization outlook.

Key investor concerns include the high price point targeting the niche emotional companionship segment, uncertainties around order conversion rates and mass production capability — with CEO Zhou Jian himself acknowledging production difficulty as historically rare — as well as intensifying competition from rivals such as Unitree Technology. Additionally, questions around UBTECH's financial sustainability amid aggressive scaling plans for both consumer and industrial robot lines have weighed on sentiment, triggering the post-event correction.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)